Historique
Bulletin de Périodique
International Journal of Drug Policy , Vol.22, n°3 - May 2011
Paru le :
01/05/2011
Année
2011
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
• How many HIV infections are prevented by Vancouver Canada's supervised injection facility? Pinkerton S.D., p. 179-183.
• Beyond human rights and public health: Citizenship issues in harm reduction. Chen J.-s., p. 184-188.
• What is the role of harm reduction when drug users say they want abstinence? Neale J., Nettleton S., Pickering L., p. 189-193.
• Abstinence and harm reduction: Can they work together? McKeganey N., p. 194-195.
• Rhetoric, reality and research: What they mean for achieving the best possible treatment system for addiction-related problems. Miller P., Dunlop A., p. 196-197.
• Doping in sport: A review of medical practitioners' knowledge, attitudes and beliefs. Backhouse S.H., McKenna J., p. 198-202.
• Amphetamine-type stimulant use and HIV/STI risk behaviour among young female sex workers in Phnom Penh, Cambodia. Maher L., Phlong P., Mooney-Somers J., Keo S., Stein E., Couture M.C., et al., p. 203-209.
• Harm reduction intensity--Its role in HAART adherence amongst drug users in Amsterdam. Lambers F.A.E., Stolte I.G., van den Berg C.H.S.B., Coutinho R.A., Prins M., p. 210-218.
• Performance and coverage of HIV interventions for injection drug users: Insights from triangulation of programme, field and surveillance data from Pakistan. Khan A.A., Khan A., p. 219-225.
• Estimating national-level syringe availability to injecting drug users and injection coverage: Switzerland, 1996-2006. Arnaud S., Jeannin A., Dubois-Arber F., p. 226-232.
• Drug policy, harm and human rights: A rationalist approach. Stevens A., p. 233-238.
• The prospect of implementing a Safer Injection Facility in San Francisco: Perspectives of community stakeholders. Wenger L.D., Arreola S.G., Kral A.H., p. 239-241.
• How many HIV infections are prevented by Vancouver Canada's supervised injection facility? Pinkerton S.D., p. 179-183.
• Beyond human rights and public health: Citizenship issues in harm reduction. Chen J.-s., p. 184-188.
• What is the role of harm reduction when drug users say they want abstinence? Neale J., Nettleton S., Pickering L., p. 189-193.
• Abstinence and harm reduction: Can they work together? McKeganey N., p. 194-195.
• Rhetoric, reality and research: What they mean for achieving the best possible treatment system for addiction-related problems. Miller P., Dunlop A., p. 196-197.
• Doping in sport: A review of medical practitioners' knowledge, attitudes and beliefs. Backhouse S.H., McKenna J., p. 198-202.
• Amphetamine-type stimulant use and HIV/STI risk behaviour among young female sex workers in Phnom Penh, Cambodia. Maher L., Phlong P., Mooney-Somers J., Keo S., Stein E., Couture M.C., et al., p. 203-209.
• Harm reduction intensity--Its role in HAART adherence amongst drug users in Amsterdam. Lambers F.A.E., Stolte I.G., van den Berg C.H.S.B., Coutinho R.A., Prins M., p. 210-218.
• Performance and coverage of HIV interventions for injection drug users: Insights from triangulation of programme, field and surveillance data from Pakistan. Khan A.A., Khan A., p. 219-225.
• Estimating national-level syringe availability to injecting drug users and injection coverage: Switzerland, 1996-2006. Arnaud S., Jeannin A., Dubois-Arber F., p. 226-232.
• Drug policy, harm and human rights: A rationalist approach. Stevens A., p. 233-238.
• The prospect of implementing a Safer Injection Facility in San Francisco: Perspectives of community stakeholders. Wenger L.D., Arreola S.G., Kral A.H., p. 239-241.
Dépouillements
Ajouter le résultat à votre sélection
S. D. PINKERTON
|
2011
Dans International Journal of Drug Policy (Vol.22, n°3, May 2011) Article : Périodique
Dans International Journal of Drug Policy (Vol.22, n°3, May 2011) Article : Périodique
Mathematical modelling analyses of drug injection-related HIV risk reduction interventions can provide policy makers, researchers, and others with important information that would be difficult to obtain through other means. The validity of the r[...]
![What is the role of harm reduction when drug users say they want abstinence? [Commentary]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_67076.webp?v=1771259805)
J. NEALE ;
S. NETTLETON ;
L. PICKERING
|
2011
Dans International Journal of Drug Policy (Vol.22, n°3, May 2011) Article : Périodique
Dans International Journal of Drug Policy (Vol.22, n°3, May 2011) Article : Périodique
Quantitative survey data indicate that most drug users starting treatment want abstinence rather than harm reduction (McKeganey et al., 2004). This finding has been seized upon by those seeking 'evidence' that abstinence is the bedrock of recove[...]
P. MILLER ;
A. DUNLOP
|
2011
Dans International Journal of Drug Policy (Vol.22, n°3, May 2011) Article : Périodique
Dans International Journal of Drug Policy (Vol.22, n°3, May 2011) Article : Périodique
S. H. BACKHOUSE ;
J. McKENNA
|
2011
Dans International Journal of Drug Policy (Vol.22, n°3, May 2011) Article : Périodique
Dans International Journal of Drug Policy (Vol.22, n°3, May 2011) Article : Périodique
BACKGROUND: Central to the work of many medical practitioners is the provision of pharmaceutical support for patients. Patients can include athletes who are subject to anti-doping rules and regulations which prohibit the use of certain substance[...]
S. ARNAUD ;
A. JEANNIN ;
F. DUBOIS-ARBER
|
2011
Dans International Journal of Drug Policy (Vol.22, n°3, May 2011) Article : Périodique
Dans International Journal of Drug Policy (Vol.22, n°3, May 2011) Article : Périodique
BACKGROUND: Measuring syringe availability and coverage is essential in the assessment of HIV/AIDS risk reduction policies. Estimates of syringe availability and coverage were produced for the years 1996 and 2006, based on all relevant available[...]
A. STEVENS
|
2011
Dans International Journal of Drug Policy (Vol.22, n°3, May 2011) Article : Périodique
Dans International Journal of Drug Policy (Vol.22, n°3, May 2011) Article : Périodique
BACKGROUND: It has recently been argued that drug-related harms cannot be compared, so making it impossible to choose rationally between various drug policy options. Attempts to apply international human rights law to this area are valid, but ha[...]
L. D. WENGER ;
S. G. ARREOLA ;
A. H. KRAL
|
2011
Dans International Journal of Drug Policy (Vol.22, n°3, May 2011) Article : Périodique
Dans International Journal of Drug Policy (Vol.22, n°3, May 2011) Article : Périodique
BACKGROUND: Government-sanctioned Safer Injection Facilities (SIFs) have been implemented around the world to address public health and public order concerns associated with injection drug use. The goal of this study was to investigate how commu[...]